Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron polymaltose versus no iron in Indigenous maintenance haemodialysis patients with anaemia
ACTRN12620000705987Phase 4Recruiting
- Sponsor
- Menzies School of Health Research
- Start
- Dec 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of iron polymaltose in anaemia (2 arms), sponsored by Menzies School of Health Research. Primary endpoint: Primary composite endpoint. Started Dec 2020; status: recruiting.
02
Drugs
iron polymaltose
03
Conditions
anaemia
Beyond the preview
Go deeper on ACTRN12620000705987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000705987.